Osprey Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4M Hold
1,997
0.62% 39
2026
Q1
$1.84M Sell
1,997
-38
-2% -$38.5K 0.53% 41
2025
Q4
$2.19M Buy
2,035
+255
+14% +$244K 0.63% 38
2025
Q3
$1.36M Buy
1,780
+1,261
+243% +$938K 0.49% 37
2025
Q2
$405K Buy
519
+59
+13% +$45.8K 0.22% 43
2025
Q1
$380K Buy
460
+25
+6% +$20.8K 0.23% 43
2024
Q4
$336K Buy
435
+10
+2% +$8.28K 0.23% 38
2024
Q3
$377K Buy
+425
New +$382K 0.26% 39

Other funds holding LLY

Osprey Private Wealth's LLY Position: Q2 2026 in Review

Osprey Private Wealth held its Eli Lilly (LLY) position steady in Q2 2026 at 1,997 shares worth $2.4M. The position accounts for 0.62% of the portfolio, ranked #39.

Osprey Private Wealth first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Osprey Private Wealth held 1,997 shares of Eli Lilly worth $2.4M as of Q2 2026.
  • Osprey Private Wealth left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.62% of Osprey Private Wealth's portfolio in Q2 2026, its #39 holding.
  • Osprey Private Wealth first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Osprey Private Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.